Anixa Biosciences, Inc. ANIX
NASDAQ · United States · Health Technology
$2.95+0.18 (+6.50%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 2026-09-09 | -0.08 | -0.08 | -1.1% | $0 | — | -5.2%$2.90→$2.75 |
| Q2 2026 | 2026-06-10 | -0.07 | -0.10 | +30.0% | — | — | +3.3%$2.40→$2.48 |
| Q1 2026 | 2026-03-09 | -0.08 | -0.09 | +11.1% | — | — | +4.6%$2.85→$2.98 |
| Q4 2025 | 2026-01-12 | -0.09 | -0.09 | 0.0% | — | — | -3.0%$3.38→$3.28 |
| Q3 2025 | 2025-09-10 | -0.07 | -0.10 | +30.0% | — | — | — |
| Q2 2025 | 2025-05-28 | -0.09 | -0.10 | +10.0% | — | — | — |
| Q1 2025 | 2025-03-11 | -0.10 | -0.10 | 0.0% | — | — | — |
| Q4 2024 | 2025-01-10 | -0.09 | -0.11 | +18.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.